Showing results (1-10 of 376) with videos related to
Sort By:
Pageof 38
Frontiers in Oncology|December 24, 2025
Rapidly evolving therapeutic advances for classical <i>EGFR</i>-mutant NSCLCKelsey Pan, Suresh S RamalingamJournal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 1, 2010
Lung cancer in HIV-positive patientsSuchita Pakkala, Suresh S RamalingamCurrent Opinion in Oncology|January 26, 2016
Adjuvant therapy for nonsmall cell lung cancer: recent advances and future perspectivesSuchita Pakkala, Suresh S RamalingamClinical Lung Cancer|April 14, 2009
Combined inhibition of vascular endothelial growth factor and epidermal growth factor signaling in non-small-cell lung cancer therapySuchita Pakkala, Suresh S RamalingamHematology/Oncology Clinics of North America|December 4, 2016
Epidermal Growth Factor Receptor Mutated Advanced Non-Small Cell Lung Cancer: A Changing Treatment ParadigmSuchita Pakkala, Suresh S RamalingamJCI Insight|August 10, 2018
Personalized therapy for lung cancer: striking a moving targetSuchita Pakkala, Suresh S RamalingamCurrent Opinion in Oncology|December 17, 2009
Antiangiogenic agents in the treatment of nonsmall cell lung cancer: reality and hopeSuresh S Ramalingam, Chandra P BelaniSeminars in Thoracic and Cardiovascular Surgery|November 29, 2008
Targeted therapy for the treatment of non-small cell lung cancer: focus on inhibition of epidermal growth factor receptorSeema Harichand-Herdt, Suresh S RamalingamMolecular Cancer Therapeutics|February 12, 2014
Advances in the diagnosis and treatment of non-small cell lung cancerRathi N Pillai, Suresh S RamalingamCancer Discovery|June 4, 2014
Second-generation ALK inhibitors: filling the non "MET" gapSuresh S Ramalingam, Fadlo R KhuriPageof 38